Lebrikizumab Shows Cost Benefits in Atopic Dermatitis Care

Source link : https://yourblogdomain.com/2025/07/17/lebrikizumab-shows-cost-benefits-in-atopic-dermatitis-care/

Source link : https://newshealth.biz/health-news/lebrikizumab-shows-cost-benefits-in-atopic-dermatitis-care/ TOPLINE: The introduction of lebrikizumab, a novel monoclonal antibody targeting interleukin-13 for severe atopic dermatitis (AD), was associated with cost savings of approximately €3.3 million over 3 years for the Italian National Healthcare System, according to a budget impact analysis model. The adoption of lebrikizumab increased from 1198 patients in year […]

—-

Author : yourblogdomain

Publish date : 2025-07-17 13:42:00

Copyright for syndicated content belongs to the linked Source.

—-

1 – 2 – 3 – 4 – 5 – 6 – 7 – 8